Professional Documents
Culture Documents
12
, ratio of reduced-form to 1st-stage
22
2 sls =
12
^
22
(w i w )( y i y ) = 12 = ^ = ^
=
2 sls
ils
(w i w )(Ti T ) ^
^
IV
22
2SLS:
1. LS of Ti on 1, wi Ti = 21 + 22 w i
^
2. LS of yi on 1, Ti
Form IV/2SLS estimator from 2 reduced-forms
See anatomy of 2SLS (how IV estimate formed)
STATA: ivreg y (T=w), robust
If wi binary (0-1), has Wald estimator interpretation (grouped
estimation)
wi = 1,
y1 , T1
wi = 0,
y0 , T0
^
y y0
IV = 1
,
u1 u0 ? X 1 X 0 ?
T1 T0
Question: How much bias does wi reduce relative to reduction in
treatment variation?
Ex.: Quarter 4 vs. Quarter 1 babies
T1 T0 = 0.1 yrs of education, very small difference
X 1 X 0 0 , mothers education
2
Ti = Ti + v i ,
Ti = exogenous component
^
22 , v i = Ti Ti
2. OLS of yi on Xi, Ti
STATA: ivreg y X (T=w), robust
2 Alternative 2nd-stages
i) use wi as instruments:
^
^
yi = Ti + X i + i , E Ti i = 0
CF = 2 sls
In finite samples, if 1st-stage weak, then 2 sls biased toward ols , and
^
regress yi on Xi, Ti
, regress i on Xi, wi R2
N R2 ~ 2(p-1), p = dim(wi)
^
D
F OMD 2 ( p 1) degrees of freedom
Choose 0
Choose 1
(0)
(bar) r
(1)
Return to College
= ATE ,
r = Marginal T.E. (effect for marginal person)
1 = Selected ATE = " Treatment on Treated Effect"
0 = Average effect for untreated
6
Ti = 1( i = y1i y0 i > r )
- Pure Roy model all variation in choice due to self-selection on
benefits relative to uniform cost.
- Cant ID T.E.s without strong parametric assumptions.
Ti = 1( y1i y0 i ci > 0 )
- Some variation in choice due to heterogeneity in costs (ci). If costs
unrelated to i and omitted vars., then can ID model using cost
variables as instruments.
- otherwsie, E( 2 sls )
Rewrite:
yi = Ti* + a i Ti* + X i + ui , = E ( i ) , ai = i
Ti* = X i 1 + w i 2 + v i
A1: E(ui|wi)=0,
wi = valid I.V.
(wi, vi) independent
A2: E(vi|wi)=0
E v i2 w i = v2
^
A1-A4 E ai Ti* wi = E ai Ti* = constant E 2 sls = E CF =
) (
Alternatively,
B1A1, B4A4
B2: E Ti* wi , a i = + X i 1 + w i 2 + a i ,
[E (vi wi , ai ) = ai ]
B3: E(ai|wi)=0
E a i2 w i = a2
E 2 sls
C1: E (ui wi ) = E (a i w i ) = 0
(
C3: E (a T
)
,w )=
*
i
(
E (a T
*
T Ti
+ w wi
)
,w )=
C1-C3 E ui Ti* , w i = T v i
i
*
i
T vi
yi = Ti* + X i + 1 v i + 2Ti* v i + i
^
Cov (ui , v i )
,
Var (v i )
2 =T =
Cov (a i , v i )
Var (v i )
to E(ai| Ti* )0
^ 2
T0i
0
Never takers
Compliers
0
1
T1i
1
Defiers
Always takers
2 sls =
2
^
^ E ( yi wi = 1) E ( yi wi = 0 )
p lim 2 sls =
= E ( y1i y0 i T1i T0 i = 1)
(
)
(
)
E
T
w
=
1
E
T
w
=
0
i i
i i
= ATE for compliers (those whose treatment status changed by
I.V. wi)
Note: Ti* continuous, 2SLS has similar interpretation (Angrist and
Imbens)
^ E g Tg*
= weighted avg. of LATEs for each group g
p lim 2 sls =
*
E Tg
( )
11
Also need , + 2 , to ID (1 0)
wi = 1 Ti = 1
Treatment status R.A.
wi = 0 Ti = 0
everyone a complier
Now: wi = (-1, 0, 1), focus on wi = (-1, 1)
Complier condition: 2 vi < + 2
^
2 p lim 2 sls = 1 0
Ti = 1( ' + 2 wi + y1i y0 i 0 )
' uniform cost of participating
Roy Model:
^
13
14
15